. Overview We are a leader in the field of gene therapy, seeking to deliver to patients suffering from rare and other devastating diseases single treatments with potentially curative results. We are advancing a focused pipeline of innovative gene therapies, including our clinical candidates for the treatment of Huntingtons disease, refractory mesial temporal lobe epilepsy (MTLE), Fabry disease, and amyotrophic lateral sclerosis caused by mutations in superoxide dismutase 1 (SOD1-ALS). Recent Pro...
Q2 FY2026 — expected 2026-09-26
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0001104659-26-021898 | EDGAR | 107K words |
| 2025-02-27 | 2024-12-31 | 0001558370-25-001699 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001558370-24-001915 | EDGAR | — |
| 2023-02-27 | 2022-12-31 | 0001558370-23-002110 | EDGAR | — |
| 2022-02-25 | 2021-12-31 | 0001558370-22-002050 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001558370-21-002186 | EDGAR | — |
| 2020-03-02 | 2019-12-31 | 0001558370-20-001883 | EDGAR | — |
| 2019-02-28 | 2018-12-31 | 0001558370-19-001305 | EDGAR | — |
| 2018-03-14 | 2017-12-31 | 0001558370-18-002042 | EDGAR | — |
| 2017-03-15 | 2016-12-31 | 0001047469-17-001589 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-29 | 2026-06-30 | 0001104659-26-087815 | EDGAR | — |
| 2025-11-10 | 2025-09-30 | 0001104659-25-108813 | EDGAR | 62K words |
| 2025-07-29 | 2025-06-30 | 0001558370-25-009694 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001558370-25-007068 | EDGAR | — |
| 2024-11-05 | 2024-09-30 | 0001558370-24-014346 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0001558370-24-010528 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001558370-24-006914 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001558370-23-017867 | EDGAR | — |
| 2023-08-01 | 2023-06-30 | 0001558370-23-012633 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001558370-23-008658 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0001558370-22-015906 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001558370-22-012523 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-29 | 0001104659-26-087808 | EDGAR | — |
| 2026-03-02 | 0001104659-26-021890 | EDGAR | 4K words |
| 2026-01-13 | 0001104659-26-003075 | EDGAR | — |
| 2026-01-09 | 0001104659-26-002317 | EDGAR | — |
| 2025-12-04 | 0001104659-25-118292 | EDGAR | — |
| 2025-11-10 | 0001104659-25-108802 | EDGAR | — |
| 2025-11-03 | 0001104659-25-105223 | EDGAR | — |
| 2025-09-29 | 0001104659-25-094011 | EDGAR | — |
| 2025-09-24 | 0001104659-25-092750 | EDGAR | — |
| 2025-09-24 | 0001104659-25-092740 | EDGAR | — |
270 total filings indexed. 238 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001590560 |
| Ticker | QURE |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Website | https://www.uniqure.com |
| Listed | 2014-02-05 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/QURE (~200 tokens, structured JSON with cryptographic provenance)